Oracle Investment Management as of June 30, 2012
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 26 positions in its portfolio as reported in the June 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Onyx Pharmaceuticals | 11.6 | $70B | 1.0M | 66450.00 | |
Tenet Healthcare Corporation | 11.4 | $68B | 13M | 5240.00 | |
Thoratec Corporation | 10.5 | $63B | 1.9M | 33580.00 | |
Acorda Therapeutics | 9.4 | $57B | 2.4M | 23560.00 | |
Elan Corporation | 8.8 | $53B | 3.6M | 14590.00 | |
Quidel Corporation | 8.6 | $51B | 3.3M | 15680.00 | |
Vivus | 5.6 | $33B | 1.2M | 28540.00 | |
MAKO Surgical | 5.5 | $33B | 1.3M | 25610.00 | |
Accuray Incorporated (ARAY) | 4.2 | $25B | 3.7M | 6815.00 | |
Opko Health (OPK) | 3.9 | $23B | 5.1M | 4600.00 | |
NxStage Medical | 3.2 | $19B | 1.1M | 16760.00 | |
MAP Pharmaceuticals | 3.2 | $19B | 1.3M | 14950.00 | |
Hansen Medical | 2.7 | $16B | 7.1M | 2270.00 | |
GTx | 2.4 | $14B | 4.0M | 3520.00 | |
Gentiva Health Services | 1.6 | $9.3B | 1.3M | 6930.00 | |
BioMarin Pharmaceutical (BMRN) | 1.5 | $9.1B | 231k | 39580.00 | |
Ironwood Pharmaceuticals (IRWD) | 1.3 | $7.8B | 566k | 13780.00 | |
Transition Therapeutics | 1.1 | $6.3B | 3.5M | 1825.97 | |
Dex (DXCM) | 1.0 | $6.0B | 461k | 12960.00 | |
WebMD Health | 0.8 | $4.5B | 222k | 20510.00 | |
Amarin Corporation (AMRN) | 0.5 | $2.9B | 200k | 14460.00 | |
Accelr8 Technology Corporation | 0.4 | $2.5B | 2.2M | 1142.01 | |
Metabolix | 0.4 | $2.2B | 1.2M | 1850.00 | |
Biogen Idec (BIIB) | 0.3 | $1.8B | 13k | 144379.94 | |
Achillion Pharmaceuticals | 0.1 | $465M | 75k | 6200.00 | |
Ladenburg Thalmann Financial Services | 0.1 | $308M | 200k | 1540.00 |